Galderma Group AG (GALDY)

OTCMKTS · Delayed Price · Currency is USD
37.77
-0.11 (-0.29%)
Mar 2, 2026, 3:32 PM EST
45.77%
Market Cap 44.90B
Revenue (ttm) 4.69B
Net Income (ttm) 378.00M
Shares Out n/a
EPS (ttm) 1.59
PE Ratio 118.79
Forward PE 45.50
Dividend 0.02 (0.06%)
Ex-Dividend Date Apr 28, 2025
Volume 59,802
Average Volume 244,366
Open 37.67
Previous Close 37.88
Day's Range 37.45 - 38.20
52-Week Range 17.27 - 42.93
Beta n/a
RSI 42.93
Earnings Date Mar 5, 2026

About Galderma Group AG

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes ACTINICA, Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, Mirvaso, NEMLUVIO, Relfydess, Benzac, Loceryl, and TRI-LUMA in therapeutic dermatology. ... [Read more]

Sector Healthcare
Founded 1981
Country Switzerland
Stock Exchange OTCMKTS
Ticker Symbol GALDY
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.